Literature DB >> 20464496

Upregulation of PTEN by peroxynitrite contributes to cytokine-induced apoptosis in pancreatic beta-cells.

Rongrong Hou1, Jing Zhang, Tao Yin, Hongwei Cao, Nanyan Zhang, Xiaomiao Li, Li Wang, Ying Xing, Deqiang Li, Qiuhe Ji.   

Abstract

Phosphatase and tensin homolog (PTEN), a tumor suppressor gene, by negatively regulating the PI3K-Akt signaling pathway, participates in multiple biological processes such as cell proliferation, apoptosis, differentiation, and migration. Recent studies show that selective deletion of PTEN in pancreatic beta-cells leads to resistance to streptozotocin (STZ)-induced diabetes, but the mechanism is unclear. One major mechanism underlying STZ toxicity is cytokine-mediated beta-cell destruction in which oxidative stress plays a key role. The present study investigated the role of PTEN in cytokine-induced beta-cell apoptosis, and further explored whether oxidative stress, particularly peroxynitrite formation, could regulate PTEN-Akt pathway. Incubation of betaTC-6 cells with cytokine mixture (IL-1beta, TNF-alpha, and IFN-gamma) or exogenous peroxynitrite significantly increased apoptotic cell percentage, elevated PTEN and p-PTEN levels, and inhibited Akt activation. Transfection with PTEN-specific siRNA protected betaTC-6 cells from cytokine or peroxynitrite-mediated cell apoptosis and partially reversed Akt inhibition. Furthermore, nitrotyrosine formation, an indicator of peroxynitrite production, was significantly elevated after cytokine treatment. Preventing peroxynitrite formation by administrating NAC/L: -NMMA, or scavenging peroxynitrite directly by UA, attenuated cytokine-induced PTEN upregulation, Akt inhibition, and beta-cell apoptosis. These findings suggest that peroxynitrite-mediated PTEN upregulation plays an important role in cytokine-induced pancreatic beta-cell apoptosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20464496     DOI: 10.1007/s10495-010-0510-z

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  6 in total

1.  Glycemic control in diabetes is restored by therapeutic manipulation of cytokines that regulate beta cell stress.

Authors:  Sumaira Z Hasnain; Danielle J Borg; Brooke E Harcourt; Hui Tong; Yonghua H Sheng; Choa Ping Ng; Indrajit Das; Ran Wang; Alice C-H Chen; Thomas Loudovaris; Thomas W Kay; Helen E Thomas; Jonathan P Whitehead; Josephine M Forbes; Johannes B Prins; Michael A McGuckin
Journal:  Nat Med       Date:  2014-11-02       Impact factor: 53.440

2.  SR-135, a peroxynitrite decomposing catalyst, enhances β-cell function and survival in B6D2F1 mice fed a high fat diet.

Authors:  Michael Johns; Robert Fyalka; Jennifer A Shea; William L Neumann; Smita Rausaria; Eliwaza Naomi Msengi; Maryam Imani-Nejad; Harry Zollars; Timothy McPherson; Joseph Schober; Joshua Wooten; Guim Kwon
Journal:  Arch Biochem Biophys       Date:  2015-04-29       Impact factor: 4.013

3.  Metformin exerts glucose-lowering action in high-fat fed mice via attenuating endotoxemia and enhancing insulin signaling.

Authors:  Zi-Yu Zhou; Li-Wei Ren; Ping Zhan; Han-Yan Yang; Dan-Dan Chai; Zhi-Wen Yu
Journal:  Acta Pharmacol Sin       Date:  2016-05-16       Impact factor: 6.150

Review 4.  Targeting the PI3K/Akt signaling pathway in pancreatic β-cells to enhance their survival and function: An emerging therapeutic strategy for type 1 diabetes.

Authors:  Inah Camaya; Sheila Donnelly; Bronwyn O'Brien
Journal:  J Diabetes       Date:  2022-02-22       Impact factor: 4.530

5.  Pentamidine Inhibits Ovarian Cancer Cell Proliferation and Migration by Maintaining Stability of PTEN in vitro.

Authors:  Yi Wu; Zhong Zhang; Zuqiang Kou
Journal:  Drug Des Devel Ther       Date:  2021-07-01       Impact factor: 4.162

6.  Role of the phosphatase PTEN in early vascular remodeling.

Authors:  Daniel G Sedding; Rebecca Widmer-Teske; Andreas Mueller; Philipp Stieger; Jan-Marcus Daniel; Dursun Gündüz; Soni Pullamsetti; Holger Nef; Helge Moellmann; Christian Troidl; Christian Hamm; Rüdiger Braun-Dullaeus
Journal:  PLoS One       Date:  2013-03-22       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.